prof. RNDr. Renata Veselská, Ph.D., M.Sc.
Professor, Section of Genetics and Molecular Biology
Office: bldg. C13/326
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7905 |
---|---|
Web: | http://www.veselska.me/ |
social and academic networks: |
---|
Total number of publications: 191
2022
-
Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors
International Journal of Molecular Sciences, year: 2022, volume: 23, edition: 15, DOI
-
Values in times of crisis: Strategic crisis management in the European Union
Year: 2022
2021
-
A selective p53 activator and anticancer agent to improve colorectal cancer therapy
Cell Reports, year: 2021, volume: 35, edition: 2, DOI
-
Kapitoly z lékařské etiky
Year: 2021, type:
-
New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling
Cancers, year: 2021, volume: 13, edition: 14, DOI
2020
-
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside
Frontiers in Oncology, year: 2020, volume: 9, edition: FEB 2020, DOI
-
Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor alpha Expression in Osteosarcoma Cell Lines
International Journal of Molecular Sciences, year: 2020, volume: 21, edition: 18, DOI
-
NANOG/NANOGP8 Localizes at the Centrosome and is Spatiotemporally Associated with Centriole Maturation
Cells, year: 2020, volume: 9, edition: 3, DOI
-
Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms
Cancers, year: 2020, volume: 12, edition: 12, DOI
-
Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities
Frontiers in Oncology, year: 2020, volume: 9, edition: JAN 10 2020, DOI